Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma.
about
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myelomaCD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cellsLymphoma: immune evasion strategiesMurine melanoma-infiltrating dendritic cells are defective in antigen presenting function regardless of the presence of CD4CD25 regulatory T cellsRequirement of cognate CD4+ T-cell recognition for the regulation of allospecific CTL by human CD4+ CD127- CD25+ FOXP3+ cells generated in MLR.The role of regulatory T cells in cancer.In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinomaDissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphoma.Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity.Soluble and membrane-bound TGF-β-mediated regulation of intratumoral T cell differentiation and function in B-cell non-Hodgkin lymphoma.PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survivalRevisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOPSoluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma.Pathophysiology of T follicular helper cells in humans and miceDenileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphomaIL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma.Maximizing tumor immunity with fractionated radiation.Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.Follicular Lymphoma Tregs Have a Distinct Transcription Profile Impacting Their Migration and Retention in the Malignant Lymph Node.Microenvironment abnormalities and lymphomagenesis: Immunological aspects.Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells.Pathogenesis of follicular lymphomaCancer immunotherapy: Strategies for personalization and combinatorial approaches.Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironmentFollicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells.Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab.Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory t cells in the granulomatous lesionsRefining the treatment of follicular lymphoma.PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells.Development of autoimmunity in lymphoma.Drug-mediated and cellular immunotherapy in multiple myeloma.The challenge of the microenvironment in B-cell lymphomas.The four types of Tregs in malignant lymphomas.Blessing or curse? Proteomics in granzyme research.T-cell-mediated antitumor immunity in B-cell non-Hodgkin lymphoma: activation, suppression and exhaustion.Regulatory B cells in anti-tumor immunity.Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis.Follicular lymphoma tumor-infiltrating T-helper (T(H)) cells have the same polyfunctional potential as normal nodal T(H) cells despite skewed differentiation.
P2860
Q24605861-BE219234-2D03-484F-9CB8-FFC631F68E2BQ24681974-86B17A9D-FFF8-4E73-A7C1-D3044CFDF31FQ28080705-B390B608-997A-4CDD-AFB5-AE075DBADA60Q28386617-9608C3B0-382A-4751-A3E5-2EE5E0A1612CQ31027865-09C038D2-9C53-47A2-9C22-5691252E5635Q33631986-18872DE3-E122-4B06-A289-7847DD1CA671Q33701036-DBF68285-04DA-4DAF-A265-259CC30F7D70Q33865610-4F5C2BBE-9C0D-473F-AEAB-F1E7477D0B80Q34041661-BD1D62F1-D7AB-4E77-8943-F9117FDC0C0EQ34049065-41C6F1CD-F64D-4ECC-A634-7ED6CA45CB4CQ34649178-CCC8A547-DB1E-4EBC-AA98-A76F20D3C0F4Q35146249-4B16E165-EC1D-40E2-9152-CCF4FC1145A5Q35146298-6503C9C2-06C3-472F-8F46-4395E4CFF3B0Q35212373-6D4430FE-C569-497F-8ACF-82E03256D65AQ35695090-6F396E28-18AD-42B5-811A-9AF2D40F7DEEQ35700316-54E17604-6239-47AA-A85F-AFAEBEE13FF5Q35858092-6A2EBD3A-C7BC-40CB-AD6E-4C279299E551Q35916615-F0104082-5E09-411F-B077-47AD1FA29356Q35924987-FC5898F8-98B3-496C-A867-64A01C254F96Q36030571-A4A01BFC-3BE7-4F9C-B466-D490A06ED56FQ36118020-BE4A7603-BB95-4924-9562-DFA14C4D40B5Q36191426-8A745C58-3FBD-43AD-B4C6-8E259077C971Q36290288-ADAF75A4-9474-4445-B32B-60FB83E0D41DQ36387028-54957674-EFA0-4991-BF00-75BFFB4FED89Q36922528-1E5919B7-5B23-40CC-8EF7-DF55F8E550F5Q37073655-2752DA07-957E-4E6D-8E99-BC428090FEB5Q37142202-23688342-6089-4471-816E-9C3CD6BC8BA8Q37162867-8C91EDA6-45DD-4DD9-A3F9-C81B37C4E15EQ37197377-586D9674-A38D-4950-A0BE-535AF0C23C0DQ37280919-72CA94DA-47B7-499A-99D6-00BD5CA09E49Q37318142-D59C2E6F-3AAC-401D-929E-A85050C69916Q37754707-CCA60B99-79A4-44CF-B8C2-1DEDACF97B53Q37773257-640250EF-5846-4EAA-8E52-2456383DF8A5Q37831956-CD971D7E-555C-4E22-9AB7-EBA0F9F4DE53Q37966000-7E8D7AAD-0F6B-44CA-A897-67BCFC93243BQ38200060-B5FF4C35-24CD-4590-8D3B-7A19D56F4072Q38344066-9DB5E6C6-82C0-45E6-B00D-5452A5B2F292Q38497066-27B15103-0755-4714-8BE4-ECB844BE65F0Q38502556-471ACAB0-CA48-4972-BEEA-A3C071039467Q38621181-CB1BF974-3990-4DAE-8508-00ECB0B8E1BE
P2860
Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Attenuation of CD8
@nl
Attenuation of CD8(+) T-cell f ...... B-cell non-Hodgkin's lymphoma.
@en
type
label
Attenuation of CD8
@nl
Attenuation of CD8(+) T-cell f ...... B-cell non-Hodgkin's lymphoma.
@en
prefLabel
Attenuation of CD8
@nl
Attenuation of CD8(+) T-cell f ...... B-cell non-Hodgkin's lymphoma.
@en
P2093
P2860
P1433
P1476
Attenuation of CD8(+) T-cell f ...... B-cell non-Hodgkin's lymphoma.
@en
P2093
Anne J Novak
Stephen M Ansell
Steven C Ziesmer
Thomas E Witzig
Zhi-Zhang Yang
P2860
P304
10145-10152
P356
10.1158/0008-5472.CAN-06-1822
P407
P577
2006-10-01T00:00:00Z